Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.
Bernardo A, Palumbo R, Pedersini R, Rota Caremoli E, Gambaro AR, Ferzi A, Riva F, Grasso D, Danova M, Tarenzi E, Torri V, Cazzaniga ME.
Bernardo A, et al. Among authors: riva f.
Clin Breast Cancer. 2017 Oct;17(6):433-440. doi: 10.1016/j.clbc.2017.03.004. Epub 2017 Mar 9.
Clin Breast Cancer. 2017.
PMID: 28366406